ACR–ACNM–ARS–SNMMI Practice Parameter for the Performance of Therapy With Radium-223 Dichloride

This updated practice parameter is intended to guide appropriately trained and credentialed physicians performing therapy with radium-223 dichloride. All aspects of patient and radioisotope management are considered, as are current indications and ongoing investigations.

Authors

Institutions

Publication Details

Journal
American Journal of Clinical Oncology
Published
2025-08-25
DOI
https://doi.org/10.1097/coc.0000000000001245
Primary Topic
Radiopharmaceutical Chemistry and Applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ACR–ACNM–ARS–SNMMI Practice Parameter for the Performance of Therapy With Radium-223 Dichloride

Babak Saboury, Phillip H. Kuo, Patrick M. Colletti, Paul E. Wallner et al.
American Journal of Clinical Oncology
Radiopharmaceutical Chemistry and Applications
article

ACR–ACNM–ARS–SNMMI Practice Parameter for the Performance of Therapy With Radium-223 Dichloride

Babak Saboury, Phillip H. Kuo, Patrick M. Colletti, Paul E. Wallner, William C. Small, B.M. Rabatic, Zachary S. Morris, Amar U. Kishan, Rathan M. Subramaniam, Curtiland Deville, Navesh Sharma, Munir Ghesani, Naomi R. Schechter, Philipose G. Mulugeta, Neeta Pandit-Tasker, Parul Barry, Stephon Alexander, Esma A. Akin
article en

Abstract

This updated practice parameter is intended to guide appropriately trained and credentialed physicians performing therapy with radium-223 dichloride. All aspects of patient and radioisotope management are considered, as are current indications and ongoing investigations.

American Journal of Clinical OncologyVol. 49(3)
City Of Hope National Medical Center (US), Memorial Sloan Kettering Cancer Center (US), University of Wisconsin–Madison (US), Johns Hopkins University (US), University of California, Los Angeles (US), Loyola University Chicago (US), George Washington University (US), RTOG Foundation (US), Hospital of the University of Pennsylvania (US), Johns Hopkins Medicine (US), Keck Hospital of USC (US), University of California, Irvine Medical Center (US), Metrogiprotrans (Russia) (RU), WellSpan Health (US), Theranostics (New Zealand) (NZ), UPMC Hillman Cancer Center (US), Washington University Medical Center (US), UC Irvine Health (US), TriHealth (US), Molecular Theranostics (United States) (US), The University of Notre Dame Australia (AU)
Openalex Percentile: Top 69%
Radiopharmaceutical Chemistry and Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.